Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-300,000
Closed -$423K 6178
2025
Q2
$423K Buy
+300,000
New +$425K ﹤0.01% 5004
2024
Q3
Sell
-14,500
Closed -$61.5K 6231
2024
Q2
$61.5K Buy
+14,500
New +$56.5K ﹤0.01% 5390
2023
Q1
Sell
-225,000
Closed -$545K 6534
2022
Q4
$545K Buy
+225,000
New +$504K ﹤0.01% 4683
2018
Q4
Sell
-516,700
Closed -$909K 3890
2018
Q3
$909K Buy
+516,700
New +$2.25M ﹤0.01% 2920
2018
Q2
Sell
-150,000
Closed -$638K 3921
2018
Q1
$638K Buy
+150,000
New +$405K ﹤0.01% 2922
2017
Q2
Sell
-250,000
Closed -$568K 3598
2017
Q1
$568K Buy
+250,000
New +$533K ﹤0.01% 2745
2016
Q4
Sell
-500,000
Closed -$1.13M 3469
2016
Q3
$1.13M Buy
+500,000
New +$1.3M ﹤0.01% 2215

Other funds holding GERN

Israel Englander's GERN Position: Q2 2026 in Review

Israel Englander increased its Geron (GERN) stake by 11% in Q2 2026, buying an estimated $1.11M and bringing the position to 8,112,267 shares worth $10.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2243.

Israel Englander first reported a position in GERN in Q3 2013 and has held it in 47 quarters since. The position peaked at $39.2M in Q2 2023. 258 funds tracked by Wall St. Rank hold GERN as of Q2 2026.

  • Israel Englander held 8,112,267 shares of Geron worth $10.4M as of Q2 2026.
  • Israel Englander bought 790,745 Geron shares in Q2 2026, an estimated $1.11M.
  • Geron made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2243 holding.
  • Israel Englander first reported a position in Geron in Q3 2013 and has held it in 47 quarters since.
  • Israel Englander's Geron position peaked at $39.2M in Q2 2023.
  • 258 funds tracked by Wall St. Rank held Geron as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.